Margarita
Sanchez del Río González
Colaboradora Médica
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (1)
2021
-
Benefit–Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm
Advances in Therapy, Vol. 38, Núm. 8, pp. 4442-4460